Pharmacovigilance quality system in accordance with EU regulations

Pharmacovigilance conference + workshop in organization of Supera Kvaliteta presents “Pharmacovigilance quality system in accordance with EU regulations ”

 

Pharmacovigilance is a set of activities related to the detection, assessment, understanding, prevention and treatment in case of side effects as well as new information about the safety of medicinal products. Pharmacovigilance is a legal and ethical obligation of each pharmaceutical company. Marketing authorization holders must have a system of pharmacovigilance with clear roles and responsibilities. Pharmacovigilance activities are defined by the guidelines of good pharmacovigilance practices. All the more stringent requirements and all the more investment in this area are expected from the pharmaceutical industry. Investing in pharmacovigilance ensures greater safety of drugs by end users.

 

The conference was held in Zagreb on 9th and 10th June 2016.

 

Clinres attended this conference.